UPDATE: Chardan Capital Markets Starts Purple Biotech Ltd. (PPBT) at Buy, PT $11, 'We forecast both CM24 and NT219 reaching the US market in 2027'
Tweet Send to a Friend
(Updated - September 8, 2022 7:52 AM EDT)
Chardan Capital Markets analyst Matthew Barcus initiates coverage on Purple Biotech ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Chardan Capital Markets analyst Matthew Barcus initiates coverage on Purple Biotech ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
